Home / Markets / Croatia

Market requirements · HR

Croatia

1 dated sources Reviewed 2026-08-20 Next review 2026-11-18

HALMED has published a general rule on online medicine sales. No notice naming research-labelled peptides directly was located.

Buyers in this market search for: peptidi veleprodaja istrazivacki Hrvatska.

Tell us the compounds you need for Croatia.Ask about Croatia

The regime

How compounds are classified in Croatia

Regulator and general rule identifiedCroatia's regulator, HALMED (Agencija za lijekove i medicinske proizvode), has published a general rule that only licensed pharmacies, specialised retail outlets, and wholesalers may sell medicines online, and only non-prescription medicines with an established self-treatment safety profile.
Applicable positionHALMED's published rule on online medicine sales is the applicable position for this market.
Prescription-only positionHALMED's published rule on online medicine sales applies: prescription medicines cannot be sold online outside licensed channels.
Enforcement posture unconfirmedNo HALMED enforcement action against a peptide seller was located; note that the absence of a Croatia-specific warning should not be read as HALMED being permissive, since it may simply not have surfaced in this search round.
Already supplying Croatia? Send the compounds and volumes you buy today and we will quote against them.Send your list

Your obligations

What a buyer in Croatia needs settled

  • Assume HALMED's general online-sales restriction (pharmacy or wholesaler-only for medicines) applies to any peptide classified as a medicinal product.
  • Do not infer permissiveness from the absence of a Croatia-specific peptide warning; we flag this gap explicitly.
  • Confirm distribution channel compliance (licensed pharmacy or wholesaler) before importing any prescription-adjacent compound.
  • Apply the EU-wide function-over-labelling default given Croatia has no peptide-specific carve-out on record.

We will ask about this at enquiry. We check the authorisations your activity requires before quoting, and we confirm the position per compound rather than for the market as a whole.

Sources

Check this yourself

Every position above traces to a dated public document. The authority, the document, the date and the link are below.

Authority and documentDateLink
HALMED
Online-sales rule for medicines
2013www.halmed.hr/Lijekovi/Za-pacijente/Novosti-o-sigurnoj-pri...

Links go to the issuing body wherever one exists. Positions change. If you are relying on any of this, check the source rather than this page.

Market brief

Take the Croatia brief as a PDF

The regime, the buyer obligations and all 1 sources, dated and linked, in one document you can forward.

Nearby

Central and Eastern Europe and nearby markets

Buyers supplying one of these usually supply the others. The requirements are not the same.

CodeMarketSources
PLPoland2 sourcesGIF and GIS have issued a joint public warning on synthetic peptides offered a...
CZCzechia2 sourcesSUKL holds that most synthetic peptides meet the functional definition of a me...
SKSlovakia3 sourcesSUKL named BPC-157, ipamorelin and melanotan directly in a July 2025 press rel...
HUHungary5 sourcesOGYEI regulates medicines under Act XCV of 2005. A case-by-case research permi...
SISlovenia2 sourcesJAZMP published a dated warning on injectable peptides in April 2026 and names...
GRGreece4 sourcesEOF issued a public warning in July 2026, and related reporting names specific...

Scope

How to use this page

A summary of the published regulatory position in Croatia as at 2026-08-20, written for procurement teams deciding how to source. Every source is dated and linked so it can be checked at origin.

It is not legal advice. Full terms of supply, including where responsibility sits, are set out in our terms of supply.

Questions

Supplying into Croatia

Do you supply into Croatia?

We supply businesses that hold the authorisations their activity requires. Whether a specific compound can be supplied into Croatia depends on that compound and on your authorisations, and we confirm it per compound at the enquiry stage.

Who carries the compliance obligation?

The importer of record and the party placing the product on the market, which is the buyer. We supply the batch documentation that supports your file. We cannot hold your authorisations for you.

How current is this page?

It was reviewed on 2026-08-20 and is scheduled for review again on 2026-11-18. Every source is dated and linked, so you can check the original.

We already supply into Croatia. What changes if we source from you?

The batch documentation. You receive a Certificate of Analysis per batch, which can be issued under your own brand. The import and market-placing responsibilities stay where they are.

Is this legal advice?

No. It is a summary of the regulatory positions those authorities have published, as at the review date above. Take advice in your own market before you rely on it.

Enquire about supply into Croatia

Tell us the compounds and your authorisations. We confirm per compound before anything ships.

Anything else you already know. All optional.

We supply businesses across the EU, and we reply within one working day.